The nomination period for the upcoming ASCO Election is now closed. ASCO staff will review recommendations to confirm eligibility of submitted names. Following the eligibility check, the ASCO ...

A multisite randomized trial of an advanced pneumatic compression device vs usual care for head and neck cancer related lymphedema: Short-term results. - ASCO ...

Transcriptomic analysis of novel tumor suppressor gene fusions in bone sarcomas ...

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

Oral Abstract Breakout Session 1: Cost, Value, and Policy in Quality ...

Diagnostic performance of <i>SHOX2</i> and <i>RASSF1A</i> gene methylation assays in malignant pleural effusion: A systematic review and meta-analysis. - ASCO ...

Outcomes with neoadjuvant chemotherapy and/or osimertinib in patients with <i>EGFR-</i>mutant resectable non-small cell lung cancers. - ASCO ...

<span>Pretreatment insights into primary sarcoma tissues using a novel approach of ex-vivo functional profiling to quantify cytotoxic and anti-proliferative effects ...

Who does this study affect? People with metastatic castration-sensitive prostate cancer (mCSPC) with alterations in the homologous recombination repair (HRR) genes What did this study find?* The phase ...

Effect of genetically engineered <em>Salmonella typhimurium </em>secreting conantokin G on PD-L1 antibody therapy and tumor regression in colorectal cancer. - ASCO ...

CHICAGO — Results from the international phase 3 AMPLITUDE clinical trial found that adding niraparib to abiraterone acetate (AKEEGA™) plus prednisone (AAP) can help slow cancer growth for people with ...